22 January 2025
22 January 2025
Panellists at the World Economic Forum 2025 meeting discussed how artificial intelligence (AI) could help close the gap in women’s health research.
Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.
The FDA placed a clinical hold on two Atara assets, following an inspection at a third-party site that also led to a CRL for Ebvallo.
The Lazcluze plus Rybrevant combination could challenge AstraZeneca’s standard-of-care Tagrisso in non-small cell lung cancer.
Galapagos' decentralised manufacturing platform is tailored to be established close to treatment centres.
The FDA’s decision marks Spravato as the first monotherapy for adults with treatment-resistant depression.
The therapy previously gained orphan and PRIME designation from the EMA.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
